In a panel discussion last year, Analytical Cannabis brought together five experts on psychedelics to discuss these new psychedelic NCEs, and to provide new perspectives on the future of the psychedelic drug development landscape.
Researchers from the University of Texas Health Science Center, San Antonio have begun a study to see if the body’s own cannabinoids can help treat Alzheimer’s disease.
Cannabis consumers in Nevada have been advised by the state’s cannabis regulator to avoid or “take caution” when consuming the “Dancing Monkey” product.
Medical cannabis patients who reported getting high are more likely to feel greater symptom relief, according to a new study.
Brady Green, head grower at UK-based medicinal cannabis firm Dalgety, explains the differences between the country's illicit and legal medical cannabis markets, and why the latter needs to be the first-choice for patients.
As of June 14, no illnesses have been linked to the products.
Analytical Cannabis' guide to temperature control during the extraction process.
Cannabis oil is just as effect at reducing the number of tics a person with Tourette’s syndrome experiences as many existing treatments, according to a new study.
The cannabis regulator in Colorado has identified ‘many examples’ of adulterated test batches, according to a recent notice.